← Evidence map

ReviewClinical & developmental immunology2010

NGcGM3 ganglioside: a privileged target for cancer vaccines.

Luis E Fernandez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

42 papers cite it

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 21048926